Alnylam Pharmaceuticals (NQ: ALNY )
252.21
-1.57
(-0.62%)
Streaming Delayed Price
Updated: 10:03 AM EDT, Sep 4, 2024
Add to My Watchlist
Headline News about Alnylam Pharmaceuticals
![](https://cdn.benzinga.com/files/images/story/2023/09/07/alny.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_4.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for Alnylam Pharmaceuticals
August 16, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/07/31/ions.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/07/25/lululemon_athletica_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Analyst Ratings for Alnylam Pharmaceuticals
June 22, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_1.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/24/tsla.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/24/alny.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/740730/hearthealth.jpg)
![](https://g.foolcdn.com/editorial/images/740166/person-in-a-lab-looking-through-a-microscope.jpg)
![](/next-assets/images/schema-image-default.png)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/07/17/image21.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/17/alny.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2018/04/stock-drugs-12-adobe.jpg)
![](/next-assets/images/schema-image-default.png)
Where Alnylam Pharmaceuticals Stands With Analysts
May 05, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_1.jpeg?width=1200&height=800&fit=crop)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
Via Talk Markets
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/06/07/covid-19_vaccination-photo_by_johaehn_from_pixabay.jpg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2023/06/A1-060523-Bigpharma-chrisgash.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/05/22/alny.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_7754.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/04/27/dementia-3051832_1920.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.